These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8672922

  • 21. Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia.
    Davidson EJ, Sehr P, Faulkner RL, Parish JL, Gaston K, Moore RA, Pawlita M, Kitchener HC, Stern PL.
    J Gen Virol; 2003 Aug; 84(Pt 8):2089-2097. PubMed ID: 12867639
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of human papillomavirus seroconversions.
    Wikström A, van Doornum GJ, Quint WG, Schiller JT, Dillner J.
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():529-39. PubMed ID: 7897345
    [Abstract] [Full Text] [Related]

  • 28. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
    Carter JJ, Madeleine MM, Shera K, Schwartz SM, Cushing-Haugen KL, Wipf GC, Porter P, Daling JR, McDougall JK, Galloway DA.
    Cancer Res; 2001 Mar 01; 61(5):1934-40. PubMed ID: 11280749
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Humoral immune response to human papillomavirus infection.
    Carter JJ, Galloway DA.
    Clin Dermatol; 1997 Mar 01; 15(2):249-59. PubMed ID: 9167909
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HPV-16-related proteins as the serologic markers in cervical neoplasia.
    Park JS, Park DC, Kim CJ, Ahn HK, Um SJ, Park SN, Kim SJ, Namkoong SE.
    Gynecol Oncol; 1998 Apr 01; 69(1):47-55. PubMed ID: 9570998
    [Abstract] [Full Text] [Related]

  • 33. Papillomavirus-like particles for serology and vaccine development.
    Kirnbauer R.
    Intervirology; 1996 Apr 01; 39(1-2):54-61. PubMed ID: 8957670
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection.
    Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N, Galloway DA.
    J Infect Dis; 2000 Jun 01; 181(6):1911-9. PubMed ID: 10837170
    [Abstract] [Full Text] [Related]

  • 36. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children.
    Cason J, Kambo PK, Best JM, McCance DJ.
    Int J Cancer; 1992 Feb 01; 50(3):349-55. PubMed ID: 1310487
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
    Hernandez BY, Ton T, Shvetsov YB, Goodman MT, Zhu X.
    Clin Vaccine Immunol; 2012 Sep 01; 19(9):1348-52. PubMed ID: 22761294
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.